Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Giant Biogene Holding Co's Enterprise Value is HK$17,016 Mil.
Giant Biogene Holding Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2,268 Mil. Therefore, Giant Biogene Holding Co's EV-to-EBIT ratio for today is 7.50.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Giant Biogene Holding Co (HKSE:02367) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Giant Biogene Holding Co's EV-to-EBIT for today is
Giant Biogene Holding Co's current Enterprise Value is HK$17,016 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2,268 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Giant Biogene Holding Co's EV-to-EBITDA for today is:
Giant Biogene Holding Co's current Enterprise Value is HK$17,016 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2,317 Mil.
Giant Biogene Holding Co's current Enterprise Value is HK$17,016 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$6,033 Mil.
Giant Biogene Holding Co's current Enterprise Value is HK$17,016 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1,959 Mil.
Giant Biogene Holding Co's current Enterprise Value is HK$17,016 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Giant Biogene Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1,488 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co Enterprise Value Related Terms
Giant Biogene Holding Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02367 vs PG, CL, EL: Enterprise Value Comparison
For the Household & Personal Products subindustry, Giant Biogene Holding Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giant Biogene Holding Co Enterprise Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Giant Biogene Holding Co's Enterprise Value falls into.
Giant Biogene Holding Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Giant Biogene Holding Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of HK$17,016 Mil mean?
Giant Biogene Holding Co (HKSE:02367) has a Enterprise Value of HK$17,016 Mil as of Sep. 16, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Giant Biogene Holding Co and its competitors.
Is Giant Biogene Holding Co's Enterprise Value too high?
Giant Biogene Holding Co's current Enterprise Value is HK$17,016 Mil. Overall, Giant Biogene Holding Co has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Giant Biogene Holding Co's Enterprise Value compare to PG and CL?
Giant Biogene Holding Co's Enterprise Value of HK$17,016 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Consumer Packaged Goods company?
A good Enterprise Value depends on the Consumer Packaged Goods industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Giant Biogene Holding Co and its competitors. Giant Biogene Holding Co's current Enterprise Value is HK$17,016 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giant Biogene Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Giant Biogene Holding Co (HKSE:02367) is currently considered Possible Value Trap. The stock's GF Value™ is HK$68.00, compared to a current price of HK$24.14 — trading 64.5% below its estimated fair value. The current Enterprise Value is HK$17,016 Mil. Giant Biogene Holding Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Giant Biogene Holding Co (HKSE:02367), the current Enterprise Value is HK$17,016 Mil as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?
Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued.
The current stock price of HK$24.14 is trading 64.5% below its estimated GF Value™ of HK$68.00.
GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.
Key valuation signals for HKSE:02367:
Enterprise Value: HK$17,016 Mil
GF Value™: HK$68.00 vs. price of HK$24.14 (64.5% below fair value)
No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score
Get the complete analysis for HKSE:02367
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02367 has been successfully added to your 
